Table 2.
Angiographic and Procedural Characteristics
| Shellac + Vitamin E–Based DCB (n = 39) | Iopromide-Based DCB (n = 39) | |
|---|---|---|
| Multivessel disease | 11 (28.2) | 10 (25.6) |
| Lesion type, B2/C | 16 (41.0) | 21 (53.9) |
| Target vessel location | ||
| Left anterior descending artery | 18 (46.2) | 19 (48.7) |
| Left circumflex artery | 10 (25.6) | 9 (23.1) |
| Right coronary artery | 11 (28.2) | 11 (28.2) |
| Mehran type | ||
| I | 19 (48.7) | 17 (43.6) |
| II | 16 (41.0) | 16 (41.0) |
| III | 4 (10.3) | 5 (12.8) |
| IV | 0 | 1 (2.6) |
| TIMI flow grade 3 before procedure | 39 (100.0) | 39 (100.0) |
| Number of study balloons | 1.0 ± 0.2 (40) | 1.1 ± 0.3 (42) |
| Study balloon diameter, mm | 3.0 ± 0.4 | 3.0 ± 0.4 |
| Study balloon length, mm | 24.6 ± 5.1 | 27.2 ± 7.0 |
| Maximum study balloon pressure, atm | 10.3 ± 2.7 | 9.8 ± 3.0 |
| Study balloon inflation time, s | 54.6 ± 12.5 | 53.9 ± 12.3 |
| Delivery time to target lesion, s | 43.8 ± 39.1 | 42.5 ± 33.2 |
| TIMI flow grade 3 at end of procedure | 39 (100.0) | 39 (100.0) |
| Bailout strategy | 0 | 0 |
Values are n (%), mean ± SD (n), or mean ± SD.
DCB = drug-coated balloon, TIMI = Thrombolysis In Myocardial Infarction.